By mimicking the activity of BH3-only molecules, small molecule BH3-mimetics can act to pharmacologically promote the release of pro-apoptotic BCL-2 family members from the anti-apoptotic proteins, thus pushing cancer cells to undergo apoptosis. This evidence concerns the gene BCL2 and cancer.